Journal article icon

Journal article

Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing.

Abstract:

Rimonabant is a cannabinoid type 1 receptor (CB1) antagonist formerly used to treat obesity, but which was withdrawn from the market in late 2008 because of its association with psychiatric adverse effects such as depression and anxiety. Previously, we showed that a single dose of rimonabant produced a negative bias on an emotional word memory task, in the absence of subjective mood effects. The present study investigated whether a similar effect on emotional processing could be seen after 7 ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1177/0269881111400649

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Role:
Author
Journal:
Journal of psychopharmacology (Oxford, England) More from this journal
Volume:
26
Issue:
1
Pages:
125-132
Publication date:
2012-01-01
DOI:
EISSN:
1461-7285
ISSN:
0269-8811
Language:
English
Keywords:
Pubs id:
pubs:139384
UUID:
uuid:21f583a2-964c-47c5-93ea-dc5a2b65d6ba
Local pid:
pubs:139384
Source identifiers:
139384
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP